AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd., a clinical-stage biotechnology company advancing oligonucleotide therapies with a focus on curing chronic hepatitis B (CHB) infection, appointed Will Wei head of chemistry, manufacturing and controls (CMC), senior vice president. Wei brings over two decades of leadership in the biotech and pharmaceutical industry. He previously held key leadership roles at global pharmaceutical companies such as GSK as a director of CMC, and Roche a...